亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢梓海生物科技有限公司  

醫藥原料,醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:秦利
  • 電話:027-84767066
  • 郵件:2625799548@qq.com
  • 傳真:027-84767066
  • QQ:2625799548
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 湖北供應***特比萘芬
湖北供應***特比萘芬
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
庫存 1000kg起訂1kg
品牌 梓海
重金屬 ≤20ppm
含量 ≥99.0%
CAS 78628-80-5
過期 長期有效
更新 2015-06-08 14:35
 
詳細信息

***特比萘芬 ***特比萘酚
英文名: TERBINAFINE HYDROCHLORIDE 
化學名稱:N-(6,6-二甲基-2-庚烯-4-炔-1-基)-N-甲基-萘甲胺***
分子式:C12H25N?HCl
分子量:327.90
CAS 登記號:78628-80-5
外觀白色或類白色結晶性粉末
溶解性微溶于水、***,易溶于無水乙醇、甲醇PH 3.0~4.5
雜質B≤0.1% 其他不明雜質≤0.05% 總雜質≤0.3% 
干燥失重≤0.5%
熾灼殘渣≤0.1%
重金屬≤20ppm
含量≥99.0%
標準EP5.311
包裝25KG/紙板桶 或 依客戶要求
適應癥: 用于治療敏感真菌所致的手癬、足癬、體癬、股癬及花紋斑癬等。 
 


©2025 武漢梓海生物科技有限公司 版權所有   技術支持:化工網   訪問量:9820  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |